Prosecution Insights
Last updated: April 19, 2026

Ampsource Biopharma Shanghai Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18492958 LINKER PEPTIDE FOR CONSTRUCTING FUSION PROTEIN LI, RUIXIANG 1674 Non-Final OA Oct 24, 2023
17290753 HOMODIMER-TYPE BISPECIFIC ANTIBODY TARGETING CD19 AND CD3, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CHASE, CAROL ANN 1646 Non-Final OA Apr 30, 2021

Managing Ampsource Biopharma Shanghai Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month